Cyclopamine Attenuates Pulmonary Arterial Hypertension Development: Implications of Hedgehog Signaling Involvement for the Pathophysiology
The FASEB Journal · 2025
DOI: 10.1096/fj.202403350r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Makito Sakurai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Veratrum Alkaloids, Hedgehog Proteins, Signal Transduction, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS), Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Pulmonary arterial hypertension (PAH) is one of the most severe pulmonary diseases. Although combination therapies of the key drugs have improved survival rates, unmet needs remain in its management. We examined the effects of cyclopamine, a Hedgehog (HH) signaling inhibitor, as a potential novel therapeutic approach for PAH. C57BL/6J male mice were exposed to 10% oxygen for 3 weeks to induce pulmonary hypertension. One week after hypoxia exposure, these mice were treated with cyclopamine or vehicle. Cyclopamine significantly attenuated right ventricular (RV) systolic pressure (H + C: 31 mmHg vs. H: 38 mmHg, p < 0.01) and RV hypertrophy (H + C: 0.28 vs. H: 0.37, p < 0.01). The fully muscularized small pulmonary arteries significantly decreased with cyclopamine (H + C: 30% vs. H: 80%, p < 0.01), suggesting a mediation by vascular remodeling inhibition. In vitro, human pulmonary arterial smooth muscle cells (HPASMC) exposed to hypoxia revealed that the inhibitory action of cyclopamine was limited to hypoxia‐promoted cell proliferation. In single‐cell RNA sequencing analysis of mice lungs treated with cyclopamine, the signaling pathways of vascular smooth muscle contraction and cGMP‐PKG, that is, key regulators in PAH development through vascular remodeling, were suppressed in cells with the characteristics of vascular endothelial and smooth muscle cells. RNA sequencing analysis of hypoxia‐exposed hPASMCs revealed that the pathways related to extracellular matrix regulation were particularly recovered. Our animal model‐based data revealed that HH signaling inhibition would improve PAH development by suppressing pulmonary vascular remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pediatrics, Japanese Red Cross Musashino Hospital, Tokyo, Japan.
- Department of Pathology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan.
- Department of Human Pathology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Bio-Informational Pharmacology, Medical Research Institute, Institute of Science Tokyo, Tokyo, Japan.
ORCID-Profile: Makito Sakurai
Förderung
- Grants-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS)
- Japan Society for the Promotion of Science
Zitieren
APA
Sakurai, M., Hosokawa, S., Yamaguchi, Y., Kirimura, S., Ihara, K., Ohashi, K., Furukawa, T., Sasano, T., Kashimada, K., & Ishii, T. (2025). Cyclopamine Attenuates Pulmonary Arterial Hypertension Development: Implications of Hedgehog Signaling Involvement for the Pathophysiology. The FASEB Journal. https://doi.org/10.1096/fj.202403350r
Vancouver
Sakurai M, Hosokawa S, Yamaguchi Y, Kirimura S, Ihara K, Ohashi K, et al. Cyclopamine Attenuates Pulmonary Arterial Hypertension Development: Implications of Hedgehog Signaling Involvement for the Pathophysiology. The FASEB Journal. 2025. doi:10.1096/fj.202403350r
BibTeX
@article{Sakurai2025,
author = {Sakurai, Makito and Hosokawa, Susumu and Yamaguchi, Yohei and Kirimura, Susumu and Ihara, Kensuke and Ohashi, Kenichi and Furukawa, Tetsushi and Sasano, Tetsuo and Kashimada, Kenichi and Ishii, Taku},
title = {Cyclopamine Attenuates Pulmonary Arterial Hypertension Development: Implications of Hedgehog Signaling Involvement for the Pathophysiology},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403350r}
}
EUVIMED